Form 8-K - Current report:
SEC Accession No. 0001628280-26-038058
Filing Date
2026-05-26
Accepted
2026-05-26 16:02:21
Documents
12
Period of Report
2026-05-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K snti-20260520.htm   iXBRL 8-K 34323
2 EX-10.1 exhibit101_formofseniorsec.htm EX-10.1 434842
  Complete submission text file 0001628280-26-038058.txt   665970

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snti-20260520.xsd EX-101.SCH 1785
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT snti-20260520_lab.xml EX-101.LAB 22530
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snti-20260520_pre.xml EX-101.PRE 13045
16 EXTRACTED XBRL INSTANCE DOCUMENT snti-20260520_htm.xml XML 2843
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 239-2030
Senti Biosciences Holdings, Inc. (Filer) CIK: 0001854270 (see all company filings)

EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40440 | Film No.: 261019619
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)